NCT00146588: Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer |
|
|
| Completed | N/A | 55 | US | Cyclophosphamide, Cytoxan, Epirubicin, Capecitabine | Craig A. Bunnell, MD, MPH, Dana-Farber Cancer Institute, Massachusetts General Hospital, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Pharmacia | Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer | 12/04 | 12/04 | | |
NCT00617370: Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility |
|
|
| Completed | N/A | 38 | US | epirubicin, cyclophosphamide, Paclitaxel, | Memorial Sloan Kettering Cancer Center, Amgen, Pfizer | Breast Cancer, Adenocarcinoma of the Breast | 07/05 | 06/08 | | |
